Bioorganic Chemistry Gordon Research Conference
New Hampshire, 11-16 June
Latest News
Upcoming Events
Amphista will be attending and/or presenting at the following conferences. If you would like to meet with us, please email info@amphista.com
Accelerating Bio-Innovation 2023
Cambridge MA, 20-21 June
2nd Annual Next Generation Degraders & Glues
London, 20-22 June
Blog
Dementia Discovery Fund invests in Amphista Therapeutics as it targets neurodegenerative diseases
Cambridge, UK – December 13, 2022 – Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced a Series B extension investment by the Dementia Discovery Fund (DDF). The investment is in recognition of the progress made in relation to Amphista’s Eclipsys™ platform and its potential to enable therapies to treat […]
Fierce Biotech Names Amphista Therapeutics as One of its “Fierce 15” Biotech Companies of 2022
Cambridge, UK – September 12, 2022 – Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced that Fierce Biotech has named it as one of 2022’s Fierce 15 biotechnology companies, designating it as one of the most promising early-stage biotechnology companies in the industry. Amphista is a world leading next-generation […]
Amphista Therapeutics appoints Dr Stuart Wood as VP, Discovery Technology
Cambridge, UK, 7 July 2022 – Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, today announced the appointment of Dr Stuart Wood as Vice President of Discovery Technology. Stuart has held a series of leadership roles in Biotech for over ten years, most recently as Chief Technology Officer at Nanna Therapeutics. […]